Click it and Unblock the Notifications
The stock of the company zoomed on the bourses after it announced its quarterly results.
The scrip of the company was trading up by 15.05 points or 3% at Rs 518.90 on the Bombay Stock Exchange (BSE).
The same trend was seen on the National Stock Exchange (NSE) as well, it was up by 15.20 points or 3.01% at Rs 519.50.
The Israel-based Taro Pharmaceutical Industries became the subsidiary unit of the company on September 20, 2010, hence the consolidated results have not been compared with the previous year's quarter, the company said in a statement.
The company's total income jumped by 42% to Rs 1,971 crore during the quarter.
It's EBITDA margin stood at 41% during the quarter.
GoodReturns.in
More From GoodReturns
Gold Price In India Rebounds After Rs 78,000/100 Gm Crash In 2 Days, Silver Rate Today Stable | March 20
Stock Market Holidays 2026: BSE, NSE To Be Shut For 4 Days From March 23 to 31: Ram Navami To Mahavir Jayanti
ATM Rules Changing From April 1, 2026: HDFC Bank, PNB, Bandhan Bank & Others Revise Cash Withdrawal Rules
Indane, HP & Bharat Gas Cylinder Booking Rules: OTP Mandatory After LPG Refilling Gap Increased to 25-45 Days
Crash in Gold Rate in India by Rs 71,400 in Single Day; Will Gold Price Today Fall Below Rs 1.50 Lakh? Outlook
Gold & Silver Rates Today Live: MCX Gold Crashes By Rs 5,645, Silver Falls By Rs 16,540; 24K, 22K, 18K Gold
1:5 Split Soon? Vedanta Ltd To Consider 3rd Interim Dividend On March 23, Share Jumps; Record Date & Buy Call
Sleeper Vande Bharat Express New Routes Identified for Long Distance Travel
Gold & Silver Rates Today Live Updates: Will 24 Carat, 22 Carat, 18 Carat See Bullish Week Ahead?
Mega Gold Price Crash Alert! 24K Sinks Rs 1.36 Lakh/100 Gm In Week; Silver Sees Losses | March 23-27 Outlook
Gold & Silver Rates Today Live: MCX Gold Ends Above Rs 1.40 Lakh, Silver Up 1%; 24K, 22K, 18K Gold On March 24
Sign in with Google